{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:37:19Z","timestamp":1792229839979,"version":"4.4.0"},"reference-count":131,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.sxmr.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T14:34:38Z","timestamp":1553006078000},"page":"274-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems"],"prefix":"10.1093","volume":"8","author":[{"given":"Dorota J.","family":"Hawksworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2019.01.002_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1365-2036.2003.01493.x","article-title":"Review article: Non-alcoholic fatty liver disease","volume":"17","author":"Alba","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.sxmr.2019.01.002_bib2","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sxmr.2019.01.002_bib3","first-page":"560","article-title":"Nonalcoholic fatty liver disease: Assessment of variability in pathologic interpretations","volume":"11","author":"Younossi","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib4","doi-asserted-by":"crossref","first-page":"E774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.sxmr.2019.01.002_bib5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","article-title":"The natural history of nonalcoholic fatty liver: A follow-up study","volume":"22","author":"Teli","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2015.10.006","article-title":"Clinical presentation and patient evaluation in nonalcoholic fatty liver disease","volume":"20","author":"Patel","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.sxmr.2019.01.002_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.annepidem.2007.05.013","article-title":"Nonalcoholic fatty liver disease","volume":"17","author":"Adams","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib8","first-page":"35","article-title":"Nonalcoholic fatty liver disease: Diagnosis and management","volume":"88","author":"Wilkins","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.sxmr.2019.01.002_bib9","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmri.24755","article-title":"Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults","volume":"41","author":"Murphy","year":"2015","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.sxmr.2019.01.002_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","article-title":"Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease: MRI accurately quantifies hepatic steatosis in NAFLD","volume":"36","author":"Permutt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.sxmr.2019.01.002_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrgastro.2018.10","article-title":"Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD","volume":"15","author":"Tapper","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.sxmr.2019.01.002_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0973-6883(12)60102-9","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"2","author":"Mishra","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2019.01.002_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00535-006-1790-5","article-title":"Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease","volume":"41","author":"Eguchi","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib16","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"Review: The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2019.01.002_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijcard.2012.09.085","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"167","author":"Brea","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clnu.2007.02.002","article-title":"Update on non-alcoholic fatty liver disease in children","volume":"26","author":"Papandreou","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/j.sxmr.2019.01.002_bib19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jpeds.2012.11.017","article-title":"Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes","volume":"162","author":"Brumbaugh","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.sxmr.2019.01.002_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cld.2015.10.003","article-title":"The progression and natural history of pediatric nonalcoholic fatty liver disease","volume":"20","author":"Goyal","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.sxmr.2019.01.002_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MPG.0000000000000520","article-title":"Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus","volume":"60","author":"Patel","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.sxmr.2019.01.002_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.sxmr.2019.01.002_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/hep.21218","article-title":"Gender, fatty liver and GGT","volume":"44","author":"Carulli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver\u00a0enzyme levels in women with type 2 diabetes: A randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib25","first-page":"2185","article-title":"Obesity: Assessment and management in primary care","volume":"63","author":"Lyznicki","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.sxmr.2019.01.002_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.26.2.133","article-title":"Liver in obesity","volume":"26","author":"Braillon","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.sxmr.2019.01.002_bib27","first-page":"349","article-title":"Liver function in moderate obesity\u2014study in 534 moderately obese subjects among 4613 male company employees","volume":"10","author":"Nomura","year":"1986","journal-title":"Int J Obes"},{"key":"10.1016\/j.sxmr.2019.01.002_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gtc.2004.12.012","article-title":"Hepatic complications of obesity","volume":"34","author":"Diehl","year":"2005","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.sxmr.2019.01.002_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver\u00a0disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib31","first-page":"97","article-title":"Liver morphology in morbid obesity: A literature study","volume":"8","author":"Andersen","year":"1984","journal-title":"Int J Obes"},{"key":"10.1016\/j.sxmr.2019.01.002_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.ijo.0800571","article-title":"Liver abnormalities in\u00a0severely obese subjects: Effect of drastic weight loss after\u00a0gastroplasty","volume":"22","author":"Luyckx","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.sxmr.2019.01.002_bib33","doi-asserted-by":"crossref","first-page":"815721","DOI":"10.1155\/2015\/815721","article-title":"OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease","volume":"2015","author":"Paschetta","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.sxmr.2019.01.002_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and natural history of\u00a0nonalcoholic fatty liver disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.sxmr.2019.01.002_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.21593","article-title":"Chronic intermittent hypoxia predisposes to liver injury","volume":"45","author":"Savransky","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib36","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.20725","article-title":"Chronic liver injury during obstructive sleep apnea","volume":"41","author":"Tann\u00e9","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A\u00a0diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1756283X16638830","article-title":"Lifestyle changes for the treatment of nonalcoholic fatty liver disease: A review of observational studies and intervention trials","volume":"9","author":"Zelber-Sagi","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.sxmr.2019.01.002_bib40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib41","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ajg.2009.238","article-title":"The relation between non-alcoholic fatty liver disease and the risk of coronary heart\u00a0disease in Koreans","volume":"104","author":"Choi","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib42","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","article-title":"Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?","volume":"54","author":"Targher","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2019.01.002_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1478-3231.2007.01531.x","article-title":"Liver: An alarm for the heart?","volume":"27","author":"Mirbagheri","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.sxmr.2019.01.002_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib46","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.sxmr.2019.01.002_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157339913804143225","article-title":"Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes","volume":"9","author":"Fu","year":"2013","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.sxmr.2019.01.002_bib49","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/1574887109666141216102458","article-title":"Role of adipokines and cytokines in non-alcoholic fatty liver disease","volume":"9","author":"Abenavoli","year":"2014","journal-title":"Rev Recent Clin Trials"},{"issue":"10C","key":"10.1016\/j.sxmr.2019.01.002_bib51","doi-asserted-by":"crossref","first-page":"40L","DOI":"10.1016\/S0002-9149(02)02963-6","article-title":"Endothelial function. From vascular biology to clinical applications","volume":"90","author":"Behrendt","year":"2002","journal-title":"Am J Cardiol"},{"issue":"6 Suppl","key":"10.1016\/j.sxmr.2019.01.002_bib52","first-page":"S17","article-title":"Endothelial dysfunction in erectile dysfunction: Role of the endothelium in erectile physiology and disease","volume":"24","author":"Bivalacqua","year":"2003","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2019.01.002_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eursup.2008.10.010","article-title":"The triad of endothelial dysfunction, cardiovascular disease, and erectile dysfunction: Clinical implications","volume":"8","author":"Montorsi","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.sxmr.2019.01.002_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1378650","article-title":"Nitric oxide: A physiologic mediator of penile erection","volume":"257","author":"Burnett","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.sxmr.2019.01.002_bib55","doi-asserted-by":"crossref","first-page":"e32785","DOI":"10.1371\/journal.pone.0032785","article-title":"Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD","volume":"7","author":"Pasarin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.sxmr.2019.01.002_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/gast.2000.9354","article-title":"Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells","volume":"119","author":"Failli","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib57","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.22285","article-title":"Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species","volume":"47","author":"Langer","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12876-015-0409-9","article-title":"Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution","volume":"15","author":"Nozaki","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12876-017-0592-y","article-title":"Non alcoholic fatty liver disease and eNOS dysfunction in humans","volume":"17","author":"Persico","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib60","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.sxmr.2019.01.002_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jama.1993.03510010089036","article-title":"NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence","volume":"270","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2019.01.002_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","article-title":"The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences","volume":"84","author":"Aytac","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2019.01.002_bib64","first-page":"460","article-title":"Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study","volume":"163","author":"Johannes","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib65","first-page":"54","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib66","first-page":"1188","article-title":"Hypertension is associated with severe erectile dysfunction","volume":"164","author":"Burchardt","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/diacare.28.5.1201","article-title":"High proportions of erectile dysfunction in men with the metabolic syndrome","volume":"28","author":"Esposito","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sxmr.2019.01.002_bib68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF03347500","article-title":"Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men","volume":"27","author":"Giugliano","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.sxmr.2019.01.002_bib69","first-page":"651","article-title":"Is the metabolic syndrome an independent risk factor for erectile dysfunction?","volume":"177","author":"Heidler","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.eururo.2006.03.035","article-title":"The metabolic syndrome and erectile dysfunction: Multiple vascular risk factors and hypogonadism","volume":"50","author":"Jackson","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib71","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1742-1241.2010.02410.x","article-title":"Erectile dysfunction and coronary artery disease prediction: Evidence-based guidance and consensus","volume":"64","author":"Jackson","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sxmr.2019.01.002_bib72","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0302-2838(03)00305-1","article-title":"Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease","volume":"44","author":"Montorsi","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib73","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/eht112","article-title":"Erectile dysfunction in the cardiovascular patient","volume":"34","author":"Vlachopoulos","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sxmr.2019.01.002_bib74","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.eururo.2005.08.002","article-title":"Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: A prospective angiographic study","volume":"48","author":"Vlachopoulos","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib75","doi-asserted-by":"crossref","first-page":"19M","DOI":"10.1016\/j.amjcard.2005.07.006","article-title":"The artery size hypothesis: A macrovascular link between erectile dysfunction and coronary artery disease","volume":"96","author":"Montorsi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib76","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehl142","article-title":"Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: The COBRA trial","volume":"27","author":"Montorsi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sxmr.2019.01.002_bib77","first-page":"2233","article-title":"Basic science evidence for the link between erectile dysfunction and cardiometabolic dysfunction","volume":"12","author":"Musicki","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2019.01.002_bib78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCOUTCOMES.112.966903","article-title":"Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: A systematic review and meta-analysis of cohort studies","volume":"6","author":"Vlachopoulos","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.sxmr.2019.01.002_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MOU.0000000000000257","article-title":"Erectile dysfunction in young patients is a proxy of overall men's health status","volume":"26","author":"Capogrosso","year":"2016","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajg.2017.02.002","article-title":"Erectile dysfunction in patients with nonalcoholic fatty liver disease","volume":"18","author":"Hasanain","year":"2017","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2014.01.014","article-title":"Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: An experimental study in the rabbit","volume":"384","author":"Vignozzi","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib82","first-page":"383","article-title":"Nonalcoholic fatty liver disease is associated with erectile dysfunction: A prospective pilot study","volume":"13","author":"Duman","year":"2016","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2019.01.002_bib83","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/MD.0000000000000550","article-title":"Case series of lipid accumulation in the human corpus cavernosum","volume":"94","author":"Alwaal","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib84","series-title":"SMSNA consensus statement and white paper executive summary: Adult-onset hyoogonadism (AOH)","year":"2015"},{"key":"10.1016\/j.sxmr.2019.01.002_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ijir.2009.46","article-title":"Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses","volume":"22","author":"Guay","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2019.01.002_bib86","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1210\/jc.2009-1796","article-title":"Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European Male Ageing Study","volume":"95","author":"Tajar","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2019.01.002_bib87","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc10-2339","article-title":"Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sxmr.2019.01.002_bib88","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e3283398ee2","article-title":"Androgens and obesity","volume":"17","author":"Allan","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.sxmr.2019.01.002_bib89","first-page":"272","article-title":"Testosterone and metabolic syndrome: A meta-analysis study","volume":"8","author":"Corona","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2019.01.002_bib90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/eje.0.1490601","article-title":"Sex hormones, inflammation and the metabolic syndrome: A population-based study","volume":"149","author":"Laaksonen","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib91","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2006.00963.x","article-title":"Association between hormones and metabolic syndrome in older Italian men","volume":"54","author":"Maggio","year":"2006","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.sxmr.2019.01.002_bib92","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/jc.2008-0054","article-title":"Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups","volume":"93","author":"Kupelian","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2019.01.002_bib93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ije\/dyq158","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome: A systematic review and meta-analysis of observational studies","volume":"40","author":"Brand","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib94","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jc.2004-0970","article-title":"The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: A prospective cohort study","volume":"90","author":"Laaksonen","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2019.01.002_bib95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13685538.2016.1154523","article-title":"Total testosterone levels are correlated to metabolic syndrome components","volume":"19","author":"Blaya","year":"2016","journal-title":"Aging Male"},{"key":"10.1016\/j.sxmr.2019.01.002_bib96","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1210\/jc.2004-2190","article-title":"Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men","volume":"90","author":"Pitteloud","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2019.01.002_bib97","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cen.12092","article-title":"The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism","volume":"78","author":"Saboor Aftab","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib98","first-page":"569","article-title":"Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men","volume":"14","author":"Corona","year":"2015","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib99","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lfs.2014.06.007","article-title":"Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice","volume":"109","author":"Kelly","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.sxmr.2019.01.002_bib100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1467-789X.2011.00978.x","article-title":"Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men","volume":"13","author":"Tian","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.sxmr.2019.01.002_bib101","doi-asserted-by":"crossref","first-page":"e100409","DOI":"10.1371\/journal.pone.0100409","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: An individual participant data meta-analysis of observational studies","volume":"9","author":"Brand","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sxmr.2019.01.002_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.2006.02560.x","article-title":"Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: The Massachusetts Male Ageing Study","volume":"65","author":"Derby","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib103","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrendo.2013.122","article-title":"Testosterone and insulin resistance in the metabolic syndrome and T2DM in men","volume":"9","author":"Rao","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib104","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/liv.13735","article-title":"Serum testosterone and non-alcoholic fatty liver disease in men and women in the US","volume":"38","author":"Yim","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.sxmr.2019.01.002_bib105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A\u00a0low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/01485010600692017","article-title":"Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men","volume":"52","author":"Osuna","year":"2006","journal-title":"Arch Androl"},{"issue":"Suppl 1","key":"10.1016\/j.sxmr.2019.01.002_bib107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00535-010-0340-3","article-title":"The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease","volume":"46","author":"Eguchi","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib108","doi-asserted-by":"crossref","first-page":"926937","DOI":"10.1155\/2013\/926937","article-title":"LPS-induced inflammation potentiates the IL-1beta-mediated reduction of LH secretion from the anterior pituitary explants","volume":"2013","author":"Herman","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib109","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/cen.12360","article-title":"Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients","volume":"80","author":"Hua","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib110","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2337\/dc09-1788","article-title":"Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men","volume":"33","author":"Li","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sxmr.2019.01.002_bib111","first-page":"545","article-title":"Sex hormone-binding globulin reduction in metabolic disorders may play a role in NAFLD development","volume":"158","author":"Saez-Lopez","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.sxmr.2019.01.002_bib112","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0043-102690","article-title":"Low serum sex hormone-binding globulin associated with insulin resistance in men with nonalcoholic fatty liver disease","volume":"49","author":"Ye","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.sxmr.2019.01.002_bib113","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMc0910143","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes","volume":"361","author":"Stefan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2019.01.002_bib114","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/aje\/kwp168","article-title":"Good semen quality and life expectancy: A cohort study of 43,277 men","volume":"170","author":"Jensen","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.eururo.2009.03.001","article-title":"Are infertile men less healthy than fertile men? Results of a prospective case-control survey","volume":"56","author":"Salonia","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib116","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/humrep\/des173","article-title":"Higher clusterin immunolabeling and sperm DNA damage levels in hypertensive men compared with controls","volume":"27","author":"Muciaccia","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.sxmr.2019.01.002_bib117","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humrep\/deu322","article-title":"The relationship between male BMI and waist circumference on semen quality: Data from the LIFE study","volume":"30","author":"Eisenberg","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.sxmr.2019.01.002_bib118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.fertnstert.2014.10.017","article-title":"Relationship between semen production and medical comorbidity","volume":"103","author":"Eisenberg","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sxmr.2019.01.002_bib119","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/MEG.0000000000000408","article-title":"Nonalcoholic fatty liver disease and alteration in semen quality and reproductive hormones","volume":"27","author":"Li","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.sxmr.2019.01.002_bib120","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1002\/anie.200460804","article-title":"Aquaporin water channels (Nobel Lecture)","volume":"43","author":"Agre","year":"2004","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.sxmr.2019.01.002_bib121","doi-asserted-by":"crossref","first-page":"E1096","DOI":"10.3390\/ijms17071096","article-title":"Hepatocyte and Sertoli cell aquaporins, recent advances and research trends","volume":"17","author":"Bernardino","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.sxmr.2019.01.002_bib122","doi-asserted-by":"crossref","first-page":"e78139","DOI":"10.1371\/journal.pone.0078139","article-title":"Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of non-alcoholic fatty liver disease","volume":"8","author":"Gena","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.sxmr.2019.01.002_bib123","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ijo.2013.234","article-title":"Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease","volume":"38","author":"Rodriguez","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.sxmr.2019.01.002_bib124","first-page":"625","article-title":"Glycerol disrupts tight junction-associated actin microfilaments, occludin, and microtubules in Sertoli cells","volume":"21","author":"Wiebe","year":"2000","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2019.01.002_bib125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2605.2004.00502.x","article-title":"Hormonal regulation of spermatogenesis","volume":"27","author":"Holdcraft","year":"2004","journal-title":"Int J Androl"},{"key":"10.1016\/j.sxmr.2019.01.002_bib126","first-page":"149","article-title":"Hormonal regulation of spermatogenesis in primates and man: Insights for development of the male hormonal contraceptive","volume":"23","author":"McLachlan","year":"2002","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2019.01.002_bib127","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.toxlet.2013.05.644","article-title":"Impairment of reproductive function in a male rat model of non-alcoholic fatty liver disease and beneficial effect of N-3 fatty acid supplementation","volume":"222","author":"Li","year":"2013","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.sxmr.2019.01.002_bib128","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.steroids.2010.06.010","article-title":"Testosterone-induced upregulation of miRNAs in the female mouse liver","volume":"75","author":"Delic","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.sxmr.2019.01.002_bib129","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1124\/dmd.113.052217","article-title":"Role of multiple microRNAs in the sexually dimorphic expression of Cyp2b9 in mouse liver","volume":"41","author":"Xie","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.sxmr.2019.01.002_bib130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2010.07.140","article-title":"Testosterone affects hormone-sensitive lipase (HSL) activity and lipid metabolism in the left ventricle","volume":"399","author":"Langfort","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sxmr.2019.01.002_bib131","first-page":"3572","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"7","author":"Montorsi","year":"2010","journal-title":"J\u00a0Sex Med"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052119300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052119300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:37:38Z","timestamp":1672774658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052119300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2050052119300058"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2019.01.002","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}